Zynteglo: payments to doctors
Payments that named Zynteglo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $358K
- Providers
- 131
- Transactions
- 221
- Average per transaction
- $1,620
The per-transaction average — $1,620 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 131 providers the average total is $2,732, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bluebird Bio, Inc. | $357,956 | 100.0% |